Melanoma antigen recognized by T-cells 1; MART-1
CAT No: ta-275
Synonyms/Alias:Melanoma antigen recognized by T-cells 1 (100-111);MART-1(100-111)
MART-1(100-111) is a synthetic peptide fragment derived from the melanoma antigen recognized by T cells 1 (MART-1), also known as Melan-A. This peptide comprises amino acids 100 to 111 of the full-length MART-1 protein, a melanocyte differentiation antigen frequently expressed in human melanomas. Due to its immunogenic properties and defined sequence, MART-1(100-111) serves as an essential molecular tool in immunological research, particularly within the context of T cell epitope mapping, antigen presentation studies, and the investigation of tumor-associated antigens. Its defined structure and biological relevance make it a valuable resource for probing mechanisms of antigen recognition and immune response modulation.
Epitope Mapping: MART-1(100-111) is extensively used in the mapping of T cell epitopes, allowing researchers to delineate the specific peptide sequences recognized by cytotoxic T lymphocytes (CTLs) in the context of melanoma. By exposing immune cells to this peptide, investigators can assess T cell specificity and reactivity, facilitating the identification of immunodominant regions within the MART-1 antigen. This application is crucial for advancing the understanding of antigenic determinants that drive anti-tumor immune responses and for refining the selection of candidate epitopes for further immunological studies.
Antigen Presentation Assays: In studies of antigen processing and presentation, MART-1(100-111) serves as a model peptide to evaluate the function of major histocompatibility complex (MHC) class I molecules and antigen-presenting cells (APCs). Researchers utilize this peptide to load APCs, such as dendritic cells, enabling controlled investigation of peptide-MHC complex formation and subsequent T cell activation. These assays provide insights into the efficiency and fidelity of antigen presentation pathways, which are fundamental for understanding immune surveillance and the development of immune-based research strategies.
T Cell Activation and Functional Studies: The peptide is widely employed in functional assays aimed at assessing CTL activation, proliferation, and cytokine secretion in response to defined antigens. By stimulating T cells with MART-1(100-111), scientists can quantify antigen-specific immune responses using techniques such as ELISPOT, flow cytometry, or intracellular cytokine staining. These experiments are instrumental in dissecting the cellular mechanisms underlying T cell-mediated recognition of melanoma cells and in evaluating the immunogenic potential of specific epitopes.
Peptide-Based Vaccine Research: MART-1(100-111) is often incorporated into experimental systems designed to explore the principles of peptide-based vaccine development. By serving as a prototypical tumor-associated antigen, it enables researchers to investigate parameters such as peptide immunogenicity, optimal delivery formats, and adjuvant combinations. These studies contribute to the rational design of immunization strategies aimed at enhancing antigen-specific T cell responses in preclinical research models.
Assay Development and Quality Control: The defined sequence and immunological relevance of MART-1(100-111) make it a standard reagent for the development and validation of immunological assays, including peptide-MHC tetramer production and T cell receptor (TCR) specificity profiling. Its use in assay standardization ensures reproducibility and reliability when measuring antigen-specific T cell populations, supporting robust experimental workflows in basic and translational immunology laboratories.
1. Emu oil in combination with other active ingredients for treating skin imperfections
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.